Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVS | ABBV | MRK | ||
| Company | Novartis Ag ADR | Abbvie Inc | Merck & Company | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 144.73 | 216.28 | 110.78 | ||
| High | 146.22 | 219.05 | 111.32 | ||
| Low | 144.45 | 214.76 | 108.59 | ||
| Latest | 145.47 | 217.88 | 109.29 | ||
| Change | +0.36 | +1.73 | -1.82 | ||
| % Change | +0.25% | +0.80% | -1.64% | ||
| Volume | 718,938 | 3,308,521 | 5,737,510 | ||
| 20-Day Average Volume | 1,417,772 | 6,101,102 | 11,372,307 | ||
| Previous Close | 145.11 | 216.15 | 111.11 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 141.40 | 223.54 | 108.36 | ||
| 20-Day Raw Stochastic | 92.87% | 30.06% | 58.95% | ||
| 20-Day Relative Strength | 66.77 | 44.77 | 60.64 | ||
| Weighted Alpha | +46.31 | +22.88 | +27.50 | ||
| Today's Opinion | 100% Buy | 8% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 8% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.40% since 01/14/26 | -1.71% since 01/14/26 | -1.47% since 01/14/26 | ||
| Low | 142.26 on 01/15/26 | 209.96 on 01/20/26 | 106.93 on 01/20/26 | ||
| High | 146.21 on 01/22/26 | 223.03 on 01/15/26 | 111.97 on 01/21/26 | ||
| 1-Month | |||||
| %Chg | +6.36% since 12/22/25 | -4.30% since 12/22/25 | +4.45% since 12/22/25 | ||
| Low | 135.55 on 01/05/26 | 209.96 on 01/20/26 | 104.32 on 12/23/25 | ||
| High | 146.35 on 01/14/26 | 237.04 on 01/07/26 | 112.90 on 01/08/26 | ||
| 3-Month | |||||
| %Chg | +10.77% since 10/22/25 | -4.63% since 10/22/25 | +24.85% since 10/22/25 | ||
| Low | 121.57 on 10/29/25 | 209.96 on 01/20/26 | 82.01 on 11/04/25 | ||
| High | 146.35 on 01/14/26 | 239.29 on 11/13/25 | 112.90 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +24.61% since 07/22/25 | +16.56% since 07/22/25 | +34.03% since 07/22/25 | ||
| Low | 112.34 on 08/01/25 | 186.77 on 07/23/25 | 76.66 on 07/29/25 | ||
| High | 146.35 on 01/14/26 | 244.81 on 10/01/25 | 112.90 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 306,533,568 | 382,020,224 | 275,777,568 | ||
| Shares Outstanding, K | 2,112,422 | 1,767,385 | 2,482,023 | ||
| Annual Sales | 51,722,000,000 | 56,334,000,000 | 64,168,000,000 | ||
| Annual Net Income | 11,941,000,000 | 4,278,000,000 | 17,117,000,000 | ||
| Last Quarter Sales | 14,358,000,000 | 15,776,000,000 | 17,276,000,000 | ||
| Last Quarter Net Income | 3,928,000,000 | 186,000,000 | 5,785,000,000 | ||
| 60-Month Beta | 0.51 | 0.36 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.25 on 10/28/25 | 1.86 on 10/31/25 | 2.58 on 10/30/25 | ||
| Latest Earnings Date | 02/04/26 | 02/04/26 | 02/03/26 | ||
| Most Recent Dividend | 2.596 on 03/12/25 | 1.730 on 01/16/26 | 0.850 on 12/15/25 | ||
| Next Ex-Dividends Date | 03/12/25 | 01/16/26 | 12/15/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 16.08 | 22.65 | 12.65 | ||